Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
IEEE Open Journal of Engineering in Medicine and Biology|June 30, 2021
The Role of CoLab and GAITS in Enabling the RADx Tech ProgramJohn M Collins, Marshall R Collins, Tamara McKenzie, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Myosin II isoform switching mediates invasiveness after TGF-β-induced epithelial-mesenchymal transitionJordan R Beach, George S Hussey, Tyler E Miller, et al.
Nutrients|June 28, 2023
Unrestricted Ketogenic Diet Feeding Enhances Epithelial Ovarian Cancer Growth In VivoMariam M AlHilli, Emily E Rhoades, Danielle Chau, et al.
Molecular Cancer Therapeutics|September 13, 2023
Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast CancerErin E Mulkearns-Hubert, Emily Esakov Rhoades, Salma Ben-Salem, et al.
Frontiers in Psychology|July 6, 2016
Attending to Race (or Gender) Does Not Increase Race (or Gender) AftereffectsNicolas Davidenko, Chan Q Vu, Nathan H Heller, et al.
Diabetes|August 22, 2008
Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese ratsRuben Nogueiras, Christelle Veyrat-Durebex, Paula M Suchanek, et al.
Biochemical and Biophysical Research Communications|June 16, 2009
Inhibition of inosine monophosphate dehydrogenase reduces adipogenesis and diet-induced obesityHua Su, Jennifer H Gunter, Melissa de Vries, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2006
Identification of substituted 4-aminopiperidines and 3-aminopyrrolidines as potent MCH-R1 antagonists for the treatment of obesityNick Kim, Kenneth M Meyers, Jose L Mendez-Andino, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2006
Novel pyrazolopiperazinone- and pyrrolopiperazinone-based MCH-R1 antagonistsKenneth M Meyers, José Méndez-Andino, Anny-Odile Colson, et al.
Journal of Ovarian Research|April 23, 2021
Pretreatment with LCK inhibitors chemosensitizes cisplatin-resistant endometrioid ovarian tumorsKatie K Crean-Tate, Chad Braley, Goutam Dey, et al.
Pageof 11